Related Experiment Video

Updated: Jan 26, 2026

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
05:48

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction

Published on: August 9, 2022

5.3K

PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease

Bailing Hsu1

  • 1Nuclear Science and Engineering Institute, University of Missouri-Columbia, Columbia, MS 65211, USA.

Journal of Biomedical Research
|November 29, 2013
PubMed

Insights

Myocardial perfusion imaging (MPI) has limitations in diagnosing coronary artery disease (CAD). Quantitative myocardial blood flow with Positron Emission Tomography (PET) offers improved accuracy for CAD diagnosis and risk prediction.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Myocardial perfusion imaging (MPI) has limitations in accurately assessing coronary artery disease (CAD), especially with complex or multi-vessel disease.
  • Existing methods struggle to differentiate between obstructive epicardial lesions and microvascular dysfunction.

Purpose of the Study:

  • To review the technical and clinical aspects of quantitative myocardial blood flow (MBF) assessment using Positron Emission Tomography (PET).
  • To highlight PET's potential to overcome MPI limitations in CAD diagnosis and risk stratification.

Main Methods:

  • Review of technical principles for quantitative myocardial blood flow (MBF) measurement with PET.
  • Discussion of clinical applications and validation studies of PET in coronary artery disease (CAD).

Main Results:

  • Quantitative MBF with PET provides absolute flow values, surpassing the relative flow limitations of MPI.
  • PET-derived MBF improves the accuracy of diagnosing and predicting outcomes in patients with coronary artery disease (CAD).

Conclusions:

  • Quantitative myocardial blood flow (MBF) assessment using Positron Emission Tomography (PET) offers a significant advancement over traditional myocardial perfusion imaging (MPI).
  • PET-based MBF quantitation is poised for broader clinical adoption to enhance coronary artery disease (CAD) diagnosis and patient risk stratification.

Keywords:
PETcoronary artery diseasemyocardial blood flow

More Related Videos

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm06:18

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

Published on: September 17, 2021

1.9K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.4K

Related Concept Videos

Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
75.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
352
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
401
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
944
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
232
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
616